NCT06419543View on ClinicalTrials.gov

Paradoxical Reactions of Remimazolam in Pediatric Painless Gastrointestinal Endoscopy

NACompletedINTERVENTIONAL
Enrollment

333

Participants

Timeline

Start Date

May 20, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2024

Conditions
Endoscopy, Gastrointestinal
Interventions
DRUG

Remimazolam

Observe the incidence of paradoxical reactions after the first induction.

Trial Locations (1)

430030

Tongji hospital, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER

NCT06419543 - Paradoxical Reactions of Remimazolam in Pediatric Painless Gastrointestinal Endoscopy | Biotech Hunter | Biotech Hunter